SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/96F187E87F5D86BF2F7DD3E69A5ACFA497455E4E9EF2B3480A978DBB94A39D346E9FD751EEAD44A89101507C4E190CD1>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/96F187E87F5D86BF2F7DD3E69A5ACFA497455E4E9EF2B3480A978DBB94A39D346E9FD751EEAD44A89101507C4E190CD1
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/96F187E87F5D86BF2F7DD3E69A5ACFA497455E4E9EF2B3480A978DBB94A39D346E9FD751EEAD44A89101507C4E190CD1
http://www.w3.org/2000/01/rdf-schema#comment
"Data suggest that serine hydroxymethyltransferase 2 (SHMT2) may be a potential target in the treatment of hepatocellular carcinoma (HCC)."
xsd:string
http://purl.uniprot.org/uniprot/#_E90DA1C6201E8D29290A07142147EBF256E3058C3979452455E20D511542B4163108B467B80B8F76ACD4CE317BA03C8F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/96F187E87F5D86BF2F7DD3E69A5ACFA497455E4E9EF2B3480A978DBB94A39D346E9FD751EEAD44A89101507C4E190CD1
http://purl.uniprot.org/uniprot/A0A0S2Z4J2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/96F187E87F5D86BF2F7DD3E69A5ACFA497455E4E9EF2B3480A978DBB94A39D346E9FD751EEAD44A89101507C4E190CD1
http://purl.uniprot.org/uniprot/#_A0A0S2Z4J2-mappedCitation-27391339
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/96F187E87F5D86BF2F7DD3E69A5ACFA497455E4E9EF2B3480A978DBB94A39D346E9FD751EEAD44A89101507C4E190CD1